Ocular Pulse Amplitude after Panretinal Photocoagulation in Normotensive Eyes with Proliferative Diabetic Retinopathy

2016 ◽  
Vol 27 (4) ◽  
pp. 481-484
Author(s):  
Marija M. Bozic ◽  
Jelena B. Karadzic ◽  
Igor M. Kovacevic ◽  
Ivan S. Marjanovic

Purpose To assess the effect of panretinal laser photocoagulation on ocular pulse amplitude (OPA) in normotensive eyes with proliferative diabetic retinopathy. Methods Prospectively, we performed unilateral argon laser panretinal photocoagulation (PRP) in 30 patients with diabetes mellitus type II and previously untreated bilateral proliferative diabetic retinopathy. Before and 7 and 30 days after the treatment, OPA was measured using dynamic contour tonometer. Results Compared with the untreated contralateral eyes, laser photocoagulation led to a reduction of OPA. Ocular pulse amplitude did not significantly differ in photocoagulated eyes 7 days after the treatment, but there was a significant difference in OPA 30 days after the treatment. The decrease in OPA values was 15% 7 days after PRP and 40% 30 days after PRP. Conclusions Ocular pulse amplitude reduction after PRP indirectly informs us about choriocapillary closure, already reported in previous studies.

Ophthalmology ◽  
1996 ◽  
Vol 103 (5) ◽  
pp. 833-838 ◽  
Author(s):  
Anthony P. Moriarty ◽  
David J. Spalton ◽  
John S. Shilling ◽  
Timothy J. Ffytche ◽  
Max Bulsara

2018 ◽  
Vol 12 (1) ◽  
pp. 308-313
Author(s):  
Arief S Kartasasmita ◽  
Prettyla Yollamanda ◽  
Grimaldi Ihsan ◽  
Rova Virgana

Objective:To compare the change in central subfield macular thickness following single-session and multiple-session laser panretinal photocoagulation in subjects with diabetic retinopathy.Methods:A single-center, randomized controlled trial study was performed on 28 eyes of 16 patients with severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy. Eyes were randomly assigned for treatment with panretinal photocoagulation performed either in single-session or multiple-session divided into three sessions during two-week period. Central subfield macular thickness was quantified using spectral domain optical coherence tomography and changes at four weeks follow-up were compared to the baseline measurement.Result:Mean baseline central subfield macular thickness of 12 eyes underwent single-session and 16 eyes underwent multiple-session panretinal photocoagulation were 342.91+109.51 micrometers and 354+171.79 micrometers (p> .05), respectively. Mean post laser central subfield macular thickness in the single-session group was 305.83+81.95 micrometers and 389.75+229.51 micrometers in the multiple-session group (p> .05). Mean central subfield macular thickness changes four weeks post laser was 37.08+94.21 micrometers for eyes treated with single-session and -35.75+123.62 micrometers for the multiple-session treated eyes (p= .101).Conclusion:There was no significant difference in change of central subfield macular thickness at four weeks post laser from treatment with single-session and multiple-session panretinal photocoagulation. Single-session panretinal photocoagulation can be used as effective multiple-session panretinal photocoagulation for the treatment of diabetic retinopathy.


2019 ◽  
Author(s):  
Fei Liu ◽  
Yan Teng ◽  
Yan Shao ◽  
Ximei Chen ◽  
Miao Zhao ◽  
...  

Abstract Objective: To investigate the safety, effectiveness and differences of combined and consecutive surgical strategies on patients with proliferative diabetic retinopathy (PDR) and severe cataract. Methods: Eighty-four cases (84 eyes) with PDR complications of vitreous hemorrhage (VH) and/or tractional retinal detachment (TRD) and severe cataract were enrolled in this retrospective analysis. Thirty-nine eyes in consecutive surgery group underwent the surgery of phacoemulsification (PHACO) and intraocular lens (IOL) implantation firstly, and then received the surgery of vitrectomy, panretinal photocoagulation (PRP) and retinopexy (when necessary) two to twenty-five days later. Forty-five eyes in combined surgery group underwent the combined surgery of PHACO, IOL implantation, vitrectomy, PRP and retinopexy (when necessary). The postoperative best corrected visual acuity (BCVA), intraocular pressure (IOP), anterior segment inflammation responses, and surgical complications were chosen as outcome measurements when the two groups were compared. Results: The demographic data of the patients before surgery had no significant difference between the two groups. There was no statistically significant difference on BCVA at postoperative week 6 between two groups (P>0.05). Postoperative inflammation of the anterior segment in combined surgery group was much more serious than that in consecutive surgery group. 91.1% patients (41 eyes) developed moderate or serious inflammation in combined surgery group at postoperative day 3 compared with 46.2% patients (18 eyes) in consecutive surgery group. In addition, there were still 71.1% patients (32 eyes) with mild or moderate inflammation in combined surgery group at postoperative week 6 compared with 28.2% patients (11 eyes) in consecutive surgery group. The IOP elevated in 20 eyes (44.4%) in combined surgery group and seven eyes (17.9%) in consecutive surgery group. The presence of posterior synechia was found in 10 eyes (22.2%) in combined group and one eye (2.6%) in consecutive group 6 weeks after surgery. Conclusion: Although both surgery strategies for PDR patients with severe cataract are safe and effective, combined surgery leads to more postoperative complications than consecutive surgery, which should be carefully monitored and properly treated. For PDR patients with severe cataract which perturbs the vitrectomy and PRP, the consecutive surgery is a priority for surgery choice if the patient's condition allows.


Sign in / Sign up

Export Citation Format

Share Document